These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 3118927)

  • 1. Calcium antagonists improve ultrafiltration in patients on continuous ambulatory peritoneal dialysis (CAPD).
    Lamperi S; Carozzi S; Nasini MG
    ASAIO Trans; 1987; 33(3):657-63. PubMed ID: 3118927
    [No Abstract]   [Full Text] [Related]  

  • 2. Effects of Ca++ and 1,25(OH)2D3 on peritoneal immune-cell cytokine release and fibroblast proliferation in CAPD patients.
    Carozzi S; Nasini MG; Schelotto C; Caviglia PM; Santoni O; Barocci S; Versace F; Cantaluppi A; Salit M; Lamperi S
    Adv Perit Dial; 1989; 5():111-20. PubMed ID: 2577390
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intraperitoneal verapamil therapy in CAPD patients with peritoneal hypopermeability. Effects on ultrafiltration.
    Lamperi S; Carozzi S; Nasini MG; Canepa M; Zanin T
    ASAIO Trans; 1988; 34(3):425-8. PubMed ID: 3196541
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lympho-monokine disorders and peritoneal fibroblast proliferation in CAPD.
    Lamperi S; Carozzi S; Nasini MG
    ASAIO Trans; 1986; 32(1):35-8. PubMed ID: 3096356
    [No Abstract]   [Full Text] [Related]  

  • 5. Cytokine-induced peritoneal fibrosis in CAPD. Effects of Ca++ and 1,25(OH)2D3.
    Carozzi S; Nasini MG; Caviglia PM; Schelotto C; Santoni O; Barocci S; Versace F; Cantaluppi A; Salit M; Lamperi S
    ASAIO Trans; 1989; 35(3):418-20. PubMed ID: 2512968
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of calcium antagonists on the peritoneal membrane in patients on CAPD.
    Vargemezis V; Pasadakis P; Thodis E
    Adv Perit Dial; 1989; 5():8-11. PubMed ID: 2577433
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of a calcium antagonist (verapamil) on the permeability of the peritoneal membrane in patients on continuous ambulatory peritoneal dialysis.
    Vargemezis V; Pasadakis P; Thodis E
    Blood Purif; 1989; 7(6):309-13. PubMed ID: 2611001
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of monophosphoryl lipid A on the in vitro function of peritoneal leukocytes from uremic patients on continuous ambulatory peritoneal dialysis.
    Carozzi S; Salit M; Cantaluppi A; Nasini MG; Barocci S; Cantarella S; Lamperi S
    J Clin Microbiol; 1989 Aug; 27(8):1748-53. PubMed ID: 2504774
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Continuous ambulatory peritoneal dialysis (CAPD).
    Swartz RD
    Compr Ther; 1983 Aug; 9(8):54-60. PubMed ID: 6617129
    [No Abstract]   [Full Text] [Related]  

  • 10. A biocompatibility study on peritoneal dialysis solution bags for CAPD.
    Carozzi S; Nasini MG; Schelotto C; Caviglia PM; Santoni O; Pietrucci A
    Adv Perit Dial; 1993; 9():138-42. PubMed ID: 8105908
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ultrafiltration failure and dialysate glucose in CAPD.
    Stegmayr B; Granbom L; Karlsson UM; Lindqvist B
    Adv Perit Dial; 1993; 9():62-4. PubMed ID: 8105964
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Alternative procedures in the therapy of chronic uremia (hemofiltration, continuing ambulatory peritoneal dialysis)].
    Scheler F
    Verh Dtsch Ges Inn Med; 1981; 87():1405-8. PubMed ID: 7331435
    [No Abstract]   [Full Text] [Related]  

  • 13. [Peritoneal blood flow, peritoneal transfer and continuous ambulatory peritoneal dialysis].
    Grzegorzewska A; Sliwowski A
    Pol Merkur Lekarski; 1997 Sep; 3(15):122-5. PubMed ID: 9461708
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of monophosphoryl lipid A (MPLA) on peritoneal leukocyte function.
    Carozzi S; Nasini MG; Schelotto C; Caviglia PM; Santoni O; Barocci S; Cantarella S; Versace F; Salit M; Cantaluppi A
    Adv Perit Dial; 1989; 5():143-50. PubMed ID: 2577398
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of heat shock proteins 47 and 70 in the peritoneum of patients on continuous ambulatory peritoneal dialysis.
    Shioshita K; Miyazaki M; Ozono Y; Abe K; Taura K; Harada T; Koji T; Taguchi T; Kohno S
    Kidney Int; 2000 Feb; 57(2):619-31. PubMed ID: 10652040
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Calcium metabolism in blood and peritoneal lymphocytes from continuous ambulatory peritoneal dialysis patients.
    Lewis SL; Kutvirt SG; Seamer LC; Holmes CJ
    Perit Dial Int; 1997; 17(3):287-94. PubMed ID: 9237291
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improved lymphocyte transformation in vitro of patients on continuous ambulatory peritoneal dialysis.
    Langhoff E; Ladefoged J
    Proc Eur Dial Transplant Assoc; 1983; 20():230-5. PubMed ID: 6657659
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lympho-monokine disorders in continuous ambulatory peritoneal dialysis.
    Carozzi S
    Contrib Nephrol; 1990; 86():128-39. PubMed ID: 2127738
    [No Abstract]   [Full Text] [Related]  

  • 19. Contribution of lymphatic absorption to loss of ultrafiltration and solute clearances in continuous ambulatory peritoneal dialysis.
    Mactier RA; Khanna R; Twardowski Z; Moore H; Nolph KD
    J Clin Invest; 1987 Nov; 80(5):1311-6. PubMed ID: 3680499
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tuberculous peritonitis in a child undergoing continuous ambulatory peritoneal dialysis.
    Tsai TC; Hsu JC; Chou LH; Lee ML
    Zhonghua Min Guo Xiao Er Ke Yi Xue Hui Za Zhi; 1994; 35(5):455-9. PubMed ID: 7942034
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.